AMSTERDAM, The Netherlands, Oct. 9, 2008 (GLOBE NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, will host a conference call on Friday, November 7, 2008 at 8:30 a.m. ET to discuss its third quarter 2008 financial results. The conference call will be hosted by Gearoid Faherty, Chief Executive Officer, and Mario Crovetto, Chief Financial Officer.
The conference call schedule is as follows:
7:00 a.m. ET: Third quarter 2008 financial results released
8:20 a.m. ET: Dial in to participate in the conference call:
-- US Participants dial 1-877-407-9039
-- International Participants dial +1-201-689-8470
8:30 a.m. ET: Conference call begins
Call Replay: A replay of the call will be available until December 7,
2008. The Account Number is: 3055; Conference ID Number: 299594.
-- US Participants dial 1-877-660-6853
-- International Participants dial +1-201-612-7415
A live webcast of the call will also be available from the Investor Relations section of the corporate web site at www.eurand.com. Following the live webcast, the archived version of the call will be available at the same URL until December 7, 2008.
About Eurand
Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies. Eurand has had four products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Eurand's technology platforms include bioavailability enhancement of poorly soluble drugs, customized release, taste-masking/fast-dissolving formulations and drug conjugation.
Eurand is a global company with facilities in the U.S. and Europe. For more information, visit Eurand's website at www.eurand.com.